Lexicon Pharmaceuticals (LXRX) Return on Sales (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Return on Sales of 0.0% for Q1 2026, up 22.0% year-over-year from 0.0% in Q1 2025, and up 91.8% quarter-over-quarter from 0.03% in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Return on Sales (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Return on Sales for 17 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Sales rose 22.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.01% (up 6.0% YoY), while the FY2025 annual figure was 0.01%, up 19.0% from the prior year.
- Return on Sales rose to 0.0% in Q1 2026 per LXRX's latest filing, from 0.03% in the prior quarter.
- Across five years, Return on Sales topped out at 0.0% in Q2 2025 and bottomed at 31.11% in Q1 2023.
- Historically, Return on Sales has averaged 6.44% across 5 years, with a median of 0.43% in 2024.
- Annual changes were most pronounced in 2022 — Return on Sales slumped 2499 bps — and 2024, when it jumped 3065 bps.
- Lexicon Pharmaceuticals' Return on Sales stood at 28.49% in 2022, then jumped by 98 bps to 0.69% in 2023, then soared by 98 bps to 0.01% in 2024, then sank by 122 bps to 0.03% in 2025, then surged by 92 bps to 0.0% in 2026.
- Business Quant data shows LXRX's Return on Sales at 0.0% in Q1 2026, 0.03% in Q4 2025, and 0.01% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 | -0.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.54% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | -0.03% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | -0.23% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.39% |
| Jun 30, 2024 | -0.35% |
| Mar 31, 2024 | -0.46% |
| Dec 31, 2023 | -0.69% |
| Sep 30, 2023 | -3.70% |
| Jun 30, 2023 | -1.77% |
| Mar 31, 2023 | -31.11% |
| Dec 31, 2022 | -28.49% |
| Sep 30, 2022 | -28.40% |
| Jun 30, 2022 | -7.47% |
| Sep 30, 2021 | -3.41% |
| Jun 30, 2021 | 1.91% |
| Mar 31, 2021 | -0.63% |